Corneal cross-linking also referred to as the CXL procedure, is being increasingly renowned as the most innovative and revolutionary para-surgical procedure of recent times designated for treatment of progressive keratoconus and related corneal ectatic disorders as well as in managing pre or post LASIK surgery complications.
It is a safe and minimally invasive procedure which involves applying liquid riboflavin (vitamin B2) to the cornea, followed by irradiation treatment using a precise ultraviolet light source. The light and riboflavin combination are known to increase the biomechanical stability of the cornea up to 300% preventing further progression of the Keratoconus disease.
LIGHTLink-CXL is the one of the newest and arguably most advanced cross linking system in the market at present, supplied as plug and treat ‘turnkey’ solution.
It is the only system in the market that is designed with the laser-like mechanisms & functionality resulting in unmatched safety, clinical effectiveness and ease of use.
LIGHTLink-CXL features exclusive built in protocols allowing for the procedures to be carried out through a guided, semi-automated process reducing potential operator error, with full customization functionality for effectible currentand next-gen cross linking treatments.
ONLY AVAILABLE FOR COMMERCIAL SALE AND DISTRIBUTION IN SELECT LOCATIONS WORLDWIDE